Xcout IntelSign inSubscribe

Bicara Therapeutics Inc.

BCAXBiotechnologyBoston, United States

Bicara Therapeutics Inc., a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts. Established in 2018, the company specializes in creating innovative, dual-action treatments specifically for solid tumors. At the forefront of their pipeline is ficerafusp alfa, a unique antibody designed to tackle solid cancers. This bifunctional therapeutic agent works by simultaneously engaging the epidermal growth factor receptor (EGFR) and binding to human transforming growth factor beta (TGF-b). Bicara Therapeutics operates as a subsidiary of Biocon Limited.

Subscribe to see Bicara Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Bicara Therapeutics Inc. at a glance

Bicara Therapeutics Inc. is a biotechnology company headquartered in Boston, United States. It is publicly listed (BCAX) with a market capitalisation of $1.2B. Xcout tracks 23 named people at Bicara Therapeutics Inc., including Claire Mazumdar Clemon (Chief Executive Officer & Director). Xcout recorded 17 job postings from Bicara Therapeutics Inc. in the last 90 days, naming tools such as NetSuite, Workday.

Industry
Biotechnology
Headquarters
Boston, United States
Market cap
$1.2B
Employees
103
Ticker
BCAX
Job postings recorded (90 days)
17
Xcout AI Rank
2/100
Xcout Green Rank
0/100

Bicara Therapeutics Inc. leadership

  • Claire Mazumdar ClemonChief Executive Officer & Director
  • Ryan CohlheppPresident, Chief Operating Officer & Director
  • Ivan HyepCFO & Treasurer
  • Jennifer LarsonCFO, Treasurer & Principal Accounting Officer
  • Jenna CohenChief Corporate Affairs Officer
  • Lara S. MeisnerChief Legal Officer, Compliance Officer & Corporate Secretary

17 more named people on record for Bicara Therapeutics Inc., with roles, board committees and tenure — see the full roster →

Hiring at Bicara Therapeutics Inc.

Xcout recorded 17 job postings from Bicara Therapeutics Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.

Tools named in Bicara Therapeutics Inc.'s job postings

NetSuiteWorkday

The weekly hiring trend, the roles and locations behind it — see Bicara Therapeutics Inc.'s hiring signals →

Tech stack

GCP

Bicara Therapeutics Inc. competitors

A few of Bicara Therapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →

Get Bicara Therapeutics Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Bicara Therapeutics Inc.? Suggest a correction

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Bicara Therapeutics Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Bicara Therapeutics Inc. in Xcout Intel

  • 23 named people with titles, LinkedIn and board committees
  • Weekly hiring history and the mix of roles behind it
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →